About Maddie Maloney
Maddie Maloney is a resigned as director on 02/18/2026 at Hawthorne Health.
Experience
This experience comes from Maddie Maloney's profile and from SEC filings. For roles taken from filings, the years are when the filings name Maddie Maloney in the role, so the role may have started earlier or lasted longer.
GO
GondolaBio Current
Associate Director of Strategy & Operations
2026 – Present
Hawthorne Health, Inc.
Resigned As Director On 02/18/2026
2025 – 2026 · Roseville, CA
Provides clinical trial services for sponsors through community sites and home visits.
AB
AbbVie
Associate Director of BD & Strategy
2026
AT
Apogee Therapeutics
Associate Director of BD & Strategy
2026
TM
Totus Medicines
Board Member
2025 – 2026
EI
Emulate, Inc.
Board Observer
2024 – 2026
CB
Code Biotherapeutics
Board Observer
2022 – 2026
NV
Northpond Ventures
Principal
2021 – 2026
KT
Kyverna Therapeutics
Board Observer
2022 – 2024
TR
TRINITY
Consultant
2019 – 2021
MC
Middlebury College
Developmental Biology and Fertility Researcher
2018 – 2019
GM
Gates Center for Regenerative Medicine
Summer Research Intern
2018
BH
Boston Children's Hospital
Pediatric Anesthesia Clinical Research Intern
2017
Key Colleagues at Startups
The people Maddie Maloney works with at each company, as listed on that company's latest Form D.
Hawthorne Health, Inc. · Form D, Aug 13, 2026
JR
Joshua Rose
Former Chief Executive Officer, Hawthorne Health and director
Jodi Akin
Founder, Hawthorne Health and director
Lucy Coassin
Chief Executive Officer, Interim and director
AC
Antonio Clapsis
Director
Richard Daly
Chairman, VieCure; Former CEO, DNAnexus
Andrea Jackson
Partner, Northpond Ventures and director
JD
Jonathan DiVincenzo
President and Chief Operating Officer, Bio-Rad Laboratories, director